Expression of connective tissue growth factor in intra-abdominal adhesions

Diseases of the Colon and Rectum

Volumn 45, Issue 11, 2002, Pages 1510-1519

  Thaler, Klaus ^a   Mack, Judith A ^a   Zhao, Rong Hua ^a   Berho, Mariana ^a   Grotendorst, Gary R ^a   Duncan, Matthew R ^a   Williams, Shawn ^a   Miranda, Julianne R ^a   Wexner, Steven D ^a   Abramson, Susan R ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Adhesions; Animal model; Connective tissue growth factor

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM ADHESION; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; STATISTICAL ANALYSIS; STUDENT T TEST; WESTERN BLOTTING;

ADHESIONS; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GASTROINTESTINAL DISEASES; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 18744399539     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6459-7     Document Type: Article

References (40)

1. Ray NF, Denton WG, Thamer M, Henderson SC, Perry S. Abdominal adhesiolysis: Inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186:1-9.
2. Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, van Goor H. Recent clinical developments in pathophysiology, epidemiology, diagnosis and treatment of intra-abdominal adhesions. Scand J Gastroenterol 2000; 35(Suppl 232):52-9.
3. Thompson JN, Whawell SA. Pathogenesis and prevention of adhesion formation. Br J Surg 1995;82:3-5.
4. Holmdahl L, Ivarsson ML. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair. Eur J Surg 1999;165:1012-9.
5. Haney AF, Doty E. The formation of coalescing peritoneal adhesions requires injury to both contacting peritoneal surfaces. Fertil Steril 1994;61:767-75.
6. Holschneider CH, Nejad F, Montz FJ. Immunomodulation with interleukin-10 and interleukin-4 compared with ketorolac tromethamine for prevention of postoperative adhesions in a murine model. Fertil Steril 1999; 71:67-73.
7. Zeyneloglu HB, Seli E, Senturk LM, Gutierrez LS, Olive DL, Arici A. The Effect of Monocyte Chemotactic Protein 1 in Intraperitoneal Adhesion Formation in a Mouse Model. 1998;179:438-43.
8. Chegini N. The role of growth factors in peritoneal healing: Transforming growth factor-β (TGF-β). Eur J Surg 1997;577(Suppl):17-23.
9. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor-β. Biochem Biophys Acta 1990;1032:79-87.
10. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol 1990;6:597-641.
11. Massague J, Boyd FT, Andres JL, et al. TGF-β receptors and TGF-β binding proteoglycan: Recent progress in identifying their functional properties. Ann N Y Acad Sci 1990;593:59-72.
12. 3 in surgically induced pelvic adhesion in rat. Obstet Gynecol 1994;83:449-54.
13. Williams RS, Rossi AM, Chegini Nasser, et al. Effect of transforming growth factor-β on postoperative adhesion formation and intact peritoneum. J Surg Res 1992; 52:65-70.
14. 1. J Surg Res 1996;65:135-8.
15. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114:1285-94.
16. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993;327:125-30.
17. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993;4:637-45.
18. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996;7:469-80.
19. Grotendorst GR. Connective tissue growth factor: A mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 1997;8:171-9.
20. Franklin TJ. Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 1997;29:79-89.
21. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107:404-11.
22. Duncan MR, Frazier KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP. FASEB J 1999;13:1774-86.
23. Mori T, Kawara S, Shinozaki M, et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 1999;181:153-9.
24. Moussad EA, Brigstock DR. Connective tissue growth factor: What's in a name? Mol Gen Metabol 2000;71:276-92.
25. Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999;30:968-76.
26. Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor (CTGF) in human renal fibrosis. Kidney Int 1998;53:853-61.
27. Sato S, Nagaoka T, Hasegawa M, et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 2000;27:149-54.
28. Oemar BS, Werner A, Garnier JM, et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997;95:831-9.
29. Grotendorst GR. Identification and development of novel anitfibrotic agents. Expert Opin Investig Drugs 1997;6:777-81.
30. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Diff 1997;8:61-8.
31. Ellis H. The etiology of postoperative abdominal adhesions: An experimental study. Br J Surg 1962;50:10-6.
32. Holtz G. Prevention and management of peritoneal adhesions. Fertil Steril 1984;41:496-7.
33. Menzies D, Ellis H. Intestinal obstruction from adhesion: How big is the problem? Ann R Coll Surg Engl 1990;72:60-3.
34. Menzies D. Peritoneal adhesions. Incidence, cause, and prevention. Surg Annu 1992;24:27-35.
35. Di Zerega GS. Contemporary adhesion prevention. Fertil Steril 1994;61:219-35.
36. Sato Y, Tsuboi R, Lucons R, Moses H, Rifkin DB. Characterization of the activation of latent TGF-β by co-culture of endothelial cells and pericytes or smooth muscle cells: A self regulating system. J Cell Biol 1990; 111:757-63.
37. Takehara K. Growth regulation of skin fibroblasts. J Dermatol Sci 2000;24(Suppl 1):S70-7.
38. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor beta (TGF-β). Growth Factors 1993;8:1-9.
39. Brattain MG, Markovitz SD, Wilson JK. Type II transforming growth factor-β receptor as a tumor suppressor gene. Curr Opin Oncol 1996;8:49-53.
40. Brigstock DR. The connective tissue growth factor/ cysteine-rich 61/nephroblastoma overexpressed (CNN) family. Endocr Rev 1999;20:189-206.